{
    "cancelStatus": "0",
    "licStatus": "1",
    "cancelDate": null,
    "cancelReason": [],
    "otherCancelReason": "",
    "licid": "52027746",
    "licUnit": "1",
    "validDate": "2029-12-03 00:00:00.000",
    "issueDate": "2019-12-03 00:00:00.000",
    "oriIssueDate": null,
    "licKind": "02",
    "oldLicid": null,
    "certNo": "DHA05202774607",
    "prodNameC": "維泰凱20毫克\/毫升口服溶液",
    "prodNameE": "VITRAKVI 20mg\/ml oral solution",
    "indicationsName": [
        "適用於有NTRK 基因融合的實體腫瘤之成人和兒童病人，並應符合以下三項條件:\r\n1、具NTRK基因融合且無已知的後天阻抗性突變(acquired resistance mutation)；\r\n2、為轉移性實體腫瘤，或手術切除極可能造成嚴重病症(severe morbidity)；\r\n3、沒有合適的替代治療選項，或於治療後發生疾病惡化。"
    ],
    "does": "1189",
    "packageUnit": [
        {
            "packageSpec": "50毫升",
            "packageUnit": "C7"
        },
        {
            "packageSpec": "2瓶",
            "packageUnit": "03"
        }
    ],
    "medMCode": "06",
    "maMedCode": "",
    "medDCode": "A",
    "mainCategory": "A",
    "drBaseId": "B51586B5-5284-498B-BA36-8D655597D329",
    "subCategory": [
        "A01"
    ],
    "ingredientsDesc": [
        "Larotrectinib"
    ],
    "restraintItemsCode": [
        "02",
        "07",
        "1S",
        "5F"
    ],
    "applicantName": "台灣拜耳股份有限公司",
    "applicantAddr": "台北市信義區信義路5段7號53樓",
    "medClass": null,
    "efficacy": " ",
    "mdFormat": null,
    "productAnnotation": "",
    "mdKind": [],
    "monitorDate": "2024-12-03",
    "licidNew": null,
    "licidOld": null,
    "factoryDtoList": [
        {
            "id": "ECE32FF2-8C4A-49CA-9576-86D31005DA00",
            "factoryCode": "1",
            "factoryName": "PENN PHARMACEUTICAL SERVICES LIMITED",
            "factoryAddr": "UNITS 23-24, TAFARNAUBACH INDUSTRIAL ESTATE, TAFARNAUBACH, TREDEGAR NP22 3AA, U.K.",
            "factoryCompanyAddr": null,
            "countryCode": "GB",
            "processCode": [],
            "processCodeStr": null,
            "factoryKind": "M",
            "factoryNo": "FGB0225000",
            "factoryInfo": null,
            "qsd": null,
            "qsdList": [],
            "factoryMadeIn": null
        },
        {
            "id": "580EA55B-88FA-4FB3-8503-D5D0773B6685",
            "factoryCode": "2",
            "factoryName": "Orion Corporation",
            "factoryAddr": "Joensuunkatu 7, Salo 24100, Finland",
            "factoryCompanyAddr": "",
            "countryCode": "FI",
            "processCode": [
                {
                    "value": "02",
                    "name": "包裝"
                }
            ],
            "processCodeStr": "02;包裝",
            "factoryKind": "M",
            "factoryNo": "FFI0031000",
            "factoryInfo": null,
            "qsd": null,
            "qsdList": [],
            "factoryMadeIn": null
        }
    ],
    "ingredientsDtoList": [
        {
            "ingredientsKind": "1",
            "ingredientsCode": "1013007500",
            "ingredientsName": "Larotrectinib",
            "ingredientsDesc": "Larotrectinib",
            "concentDesc": "(LAROTRECTINIB SULFATE…………………. ….24.600 mg g)",
            "concent": "20.0000",
            "concentUnit": "001",
            "seq": "1",
            "prescription_seq": "3",
            "prescription_Kind": "1"
        }
    ],
    "authDtoList": [],
    "iomDtoList": [],
    "changeDtoList": [],
    "atcList": [
        {
            "isMain": "1",
            "atcCode": "L01EX12"
        }
    ],
    "licBaseId": "75DF63AE-DAB8-446B-AB96-4FBE251823F2"
}